Hongchao He (He Hongchao)

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 7

Top Topics

Renal Cell Carcinoma

Transcription Factor

Oxidative Stress

Computed Tomography

Top Venues

Cancer research

Journal of cellular and molecular medicine

Journal of translational medicine

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Juan Ji, Fen Chen, Wenfang He, Li Zhao, Bo Lin, Danna Zheng, Li Chen, Hongchao He, Qiang He
YAP-activated SATB2 is a coactivator of NRF2 that amplifies anti-oxidative capacity and promotes tumor progression in renal cell carcinoma. Cancer research (2023)
Juan Ji, Fen Chen, Wenfang He, Li Zhao, Bo Lin, Danna Zheng, Li Chen, Hongchao He, Qiang He
YAP-Activated SATB2 Is a Coactivator of NRF2 That Amplifies Antioxidative Capacity and Promotes Tumor Progression in Renal Cell Carcinoma. Cancer research 83 (5) (2023)
Juan Ji, Fen Chen, Wenfang He, Li Zhao, Bo Lin, Danna Zheng, Li Chen, Hongchao He, Qiang He
YAP-Activated SATB2 Is a Coactivator of NRF2 That Amplifies Antioxidative Capacity and Promotes Tumor Progression in Renal Cell Carcinoma. Cancer research 83 (5) (2023)
Juan Ji, Fen Chen, Wenfang He, Li Zhao, Bo Lin, Danna Zheng, Li Chen, Hongchao He, Qiang He
YAP-Activated SATB2 Is a Coactivator of NRF2 That Amplifies Antioxidative Capacity and Promotes Tumor Progression in Renal Cell Carcinoma. Cancer research 83 (5) (2023)
Hongchao He, Zhijia Jin, Jun Dai, Haofei Wang, Jianqi Sun, Danfeng Xu
Computed tomography-based radiomics prediction of CTLA4 expression and prognosis in clear cell renal cell carcinoma. Cancer medicine (2022)
Liu Yihan, Wang Xiaojing, Liu Ao, Zhang Chuanjie, Wang Haofei, Shen Yan, Hongchao He
SIRT5 functions as a tumor suppressor in renal cell carcinoma by reversing the Warburg effect. Journal of translational medicine 19 (1) (2021)
Hongchao He, Ran Zhuo, Jun Dai, Xiaojing Wang, Xin Huang, Haofei Wang, Danfeng Xu
Chelerythrine induces apoptosis via ROS-mediated endoplasmic reticulum stress and STAT3 pathways in human renal cell carcinoma. Journal of cellular and molecular medicine 24 (1) (2019)